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Abstract

Left ventricular non-compaction cardiomyopathy is a genetic disorder
characterized by the presence of two myocardial layers with numerous prominent
trabeculations and deep inter-trabecular recesses that communicate with the
ventricular cavity. The diagnosis is often challenging because excessive trabeculations
may also be a normal finding in performance athletes and black people.
Echocardiography is the gold standard for diagnosis of this condition, but other
useful diagnostic techniques may include cardiac magnetic resonance imaging,
computed

tomography,

and

contrast

ventriculography.

Moreover,

newer

echocardiographic methods such as three-dimensional imaging and speckle tracking
analysis promise to improve the diagnosis of left ventricular non-compaction
cardiomyopathy. The purpose of this paper is to review the pathogenesis, diagnosis,
and management of this disease.
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Introduction
Left ventricular non-compaction (LVNC) or ‘spongy
myocardium’ is a congenital disorder characterized by
the presence of a thin epicardial layer and an excessively
trabeculated endocardial layer. This particular spongious
aspect of the myocardium was first described more than
eight decades ago in association with aortic atresia and
coronary-to-chamber fistula during the autopsy of a
newborn with complex congenital abnormalities (1). The
introduction

of

two-dimensional

echocardiography

facilitated the evaluation of left ventricle (LV) anatomy
and continuously increased the number of cases
diagnosed. In 1984 Engberding described the presence
of ‘sinusoids’ within the LV, but it was not until 1990
that the first diagnostic echocardiographic criteria of
LVNC were proposed and terminology was established
(2, 3).
Despite current developments in cardiac imaging

Figure 1. Classification of primary (predominantly
involving the heart) cardiomyopathies according to
ESC and AHA. AHA, American Heart Association;
ARVD, Arrythmogenic right ventricle dysplasia; CM,
cardiomyopathy; DCM, dilated cardiomyopathy; ESC,
European Society of Cardiology; HCM, hypertrophic
cardiomyopathy; LVNC, left ventricle noncompaction.

Discussion

and genetic diagnostic techniques, it is yet controversial
whether left ventricular non-compaction cardiomyopathy

Prevalence

is a distinct cardiomyopathy or a morphologic feature

The prevalence of LVNC in the general population

shared by different types of cardiomyopathy (4). Recent remains unknown, although in echocardiographic series
data, for example, have found that a significant it is reported around 0.14-1.3%. Isolated ventricular nonproportion of asymptomatic individuals free from compaction has an incidence of 0.01-0.26% in
cardiovascular disease met all currently used magnetic observational studies (8, 9). In a pediatric population
resonance imaging (MRI) diagnostic criteria for LVNC, with any type of primary cardiomyopathy, LVNC was
suggesting that the condition is an anatomical phenotype diagnosed in 9.2%, being the most frequent form after
rather than a distinct cardiomyopathy (5). To add to the dilated and hypertrophic cardiomyopathy (10). Left
controversy, non-compacted myocardium has been ventricular

non-compaction

in

children

is

often

categorized as unclassified cardiomyopathy by the associated with anatomical abnormalities such as septal
European Society of Cardiology (ESC) in the recently or atrial defects, congenital aortic stenosis, and aortic
published report on the definition and classification of coarctation, although studies have failed to demonstrate
cardiomyopathies (6), whereas the American Heart any direct relation among these conditions. Furthermore,
Association (AHA) classifies it as a primary genetic non-compacted myocardium has been found in patients
cardiomyopathy (7) (Figure 1).

with neuromuscular diseases such as Becker muscular
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dystrophy, Friedrich ataxia, myotonic dystrophy, or overload.

underestimate

the

one

large-scale

study,

excessive

trabeculation of the LV was found in up to 18% of

mitochondrial diseases.
Nevertheless,

In

published

rates

prevalence

of

may
LVNC.

well highly trained athletes. Nonetheless, only 0.9% of these
Better athletes also presented with ECG changes and

echocardiographic imaging and LVNC awareness will echocardiographic signs of systolic function depression
(13). Development of the ‘de novo’ hypertrabeculation
likely lead to a better recognition of this pathology.
has been observed in more than 25% of pregnant women

Pathogenesis

The mechanisms of non-compaction are not yet fully and is related to LV overload and mechanisms of
understood. The main morphogenetic anomaly is physiological adaptation to pregnancy. A similar
represented by the cessation of compaction of ventricular anatomical aspect was described in patients suffering
endomyocardium during intrauterine development. If from sickle cell disease and chronic renal failure (14)
this process does not progress normally, the LV due to an exaggerated response to the increase in
develops as a two-layered structure, with a thick non- preload. These examples challenge the embryogenesis
compacted endocardial layer and a thin compact theory and suggest involvement of acquired pathogenetic
epicardial layer, mostly observed in the inferior, lateral mechanisms or epigenetic factors. Given these
considerations a recent review recommends cautious

and apical segments.

During myocardial embryonic development, the diagnostic labeling of LVNC as a cardiomyopathy (15).
muscular fibers lose their connections, resulting in a

Genetics

weak fiber network, with recesses that connect the

LVNC is a heterogeneous, familial, or sporadic

myocardial wall with the ventricular cavity. Only in the genetic

disorder.

Genetic

studies

have

strongly

5th or 6th week of gestation does this fiber and suggested that the disease has a pattern of inheritance
intertrabecular recesses network begin the compaction (18% to 50% of cases are familial). The family form
process, starting from the base towards the apex and appears more frequently in adults with isolated LVNC
from the endocardium to the epicardium. This process than in the case of children, and it can be autosomal
implies the secretion of endothelial growth factors, such dominant, X-linked, or mitochondrial. Mutations of
as neuregulins and angiopoietins. For reasons still genes that code sarcomeric proteins (ACTC1 - cardiac
unknown, this process ceases in patients with LVNC, alpha actinin, MYH7 - beta myosin heavy chain, TNNT2
resulting in a thick non-compacted endomyocardial layer - Troponin T, G4.5-tafazzin - responsible for Barth
with prominent trabeculae and deep recesses that syndrome, TMP1-tropomyosin, MYBPC3 - binding
communicate with the LV cavity and a thin compacted protein C) (16-18), cytoskeletal and Z-line components
epicardial layer.

This embryologic hypothesis is (LDB3 - binding protein 3) (19), nuclear envelope

supported by the fact that LVNC is frequently associated proteins (LMNA-laminin A/C) (20) and ion-channels
with other congenital heart abnormalities (11). Other (SNC5A - RYR2) (21) have been identified in patients
theories suggest that ventricular non-compaction might with

ventricular

non-compaction.

Moreover,

the

be the consequence of a cardiac neuropathy or the result hypertrabecular and non-compacted aspect of the left
of a malfunction of gap junctions (12).

ventricle has also been associated with monogenic

The trabecular phenotype in LVNC can also develop syndromes such as Danon disease (22) or, in a few cases,
during adulthood as a response to left ventricular Anderson-Fabry disease (23). Other genetic conditions
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that coexist with the spongious feature of the LV pathology, when echocardiographic examination is
myocardium are Duchenne muscular dystrophy (24), suboptimal.
mitochondrial myopathies (9), chromosomal disorders,

Echocardiographic diagnosis criteria

and congenital heart disease. Specific mutations in genes

Transthoracic bidimensional echocardiography (2D-

of the Notch1 pathway (mindbomb homolog 1) in mice TTE) is the method of choice for diagnosing LVNC
and humans leading to dysregulated signaling and (Figure 2-4). Three basic echocardiographic criteria have
hypertrabeculation and non-compaction (25), as well as been proposed to define LVNC: a thick myocardium
mutations in the G4.5 gene that result in a severe, with a non-compacted layer and a compacted one;
infantile, X-linked form of LVNC, suggest strongly that prominent trabeculations; and deep endomyocardial
LVNC is a cardiomyopathy.

recesses.

It is therefore both important and challenging to
distinguish

whether

LVNC

is

an

Several echocardiographic derived algorithms for

isolated diagnosing LVNC have been proposed (3, 26, 27). The

characteristic first echocardiographic criterion has defined ventricular
associated with other cardiac disorders. Previous studies wall non-compaction as the ratio X / Y < 0.5, where X
suggest that a detailed analysis of the family background represents the distance from the epicardial surface to the
cardiomyopathy

or

an

anatomical

trabecular recesses and Y is the distance from the

in patients diagnosed with LVNC is justified.

epicardial surface to the peak of trabeculae, measured in

Physiopathology
The two myocardial layers and the trabeculae are
vascularized by the epicardial coronary arteries and the
intertrabecular

recesses

ventricular cavity.

receive

blood

from

the

Endocardial hypoperfusion arises

because of a discrepancy between the number of
capillaries and the myocardial mass. As a consequence

parasternal short axis for the apex and apical sections for
the left ventricular free wall (3). Others have proposed a
ratio

between

non-compacted

and

compacted

myocardium greater than 2:1 at end systole, in apical
short axis section, in the absence of other cardiac
disorders (26) for the diagnosis of LVNC. The
trabeculae are usually situated at the apex / lateral wall,

of ischemia, fibrosis will expand progressively and will

medium wall / inferior wall of the left ventricle. Most of
ultimately determine left ventricular systolic function the non-compacted segments are hypokinetic.
depression which will predispose to ventricular Stollberger et al. (27) defined LVNC as the presence of
arrhythmias. LVNC is a potential thromboembolic more than three trabeculae in the left ventricular wall,
disease due to the blood stagnation in the intertrabecular with trabeculae situated at the apex, visible in a single
recesses which predisposes to clot formation, which can imaging plan. The flow between the inter-trabecular
embolize in systemic circulation.

recesses can be identified by using the color Doppler

Imaging and Diagnosis

method. A fourth criterion has been proposed by

A multimodal diagnostic approach is the current Belanger et al. (28), who diagnosed LVNC using
recommendation
Echocardiography,

for
although

LVNC
dependent

diagnosis. planimetric echocardiography to measure the trabeculae
on

the in apical 4 chambers section. They divided the patients

echocardiographer’s skills and the echocardiographic by the area of left ventricular non-compaction into 3
window, remains the primary diagnostic method. Other groups: mild (< 2.5 cm2), moderate (2.5-4.9 cm2) and
imaging methods such as cardiac MRI can diagnose the severe (> 5 cm2). Based on a study on 380 patients,
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15.8% were diagnosed with LVNC. However, their cardiomyopathy there is a significant increase in
criteria have not been validated as there was no longitudinal deformation from base to apex, in subjects
correlation with the modified Jenni et al. criteria.

with LVNC, apical strain was only mildly and not
significantly

increased

(30).

Three-dimensional

echocardiography and contrast echocardiography may
bring additional valuable data to the dimensional
assessment in patients with LVNC by providing an
accurate evaluation of the number of trabeculae,
compacted segments, and intertrabecular recesses (31).

Figure
2. Bidimensional transthoracic echocardiography, short axis view of the left ventricle apex.
Note the excessive trabeculation in the infero-posterolateral region. Red line indicates the distance from the
epicardial line to the beginning of the trabeculae (7 mm)
and yellow line marks the thickness of the trabeculae
(17 mm).

Figure 4. Speckle tracking echocardiography analysis,
bull’s eye and regional strain curves (the same patient as
in figure 2). Mildly decreased global longitudinal strain,
with a value of -16.2%. Deformation is lower in the
basal segments and normal in the midwall and apical
segments. This may be explained by the globular shape
of the LV and the presence of trabeculae in the apex.

Cardiac Magnetic Resonance criteria
Cardiac magnetic resonance imaging is continually
evolving and may contribute to a more accurate
identification of LVNC.
Figure 3. Bidimensional transthoracic echocardiography, apical 3-chamber view (the same patient
as in figure 2). The hypertrabeculation can be observed
in the mid and apical region of the posterior wall
(yellow arrows).

Cardiac MRI is particularly

useful in patients in whom the apex is difficult to
visualize with echocardiography. Two sets of MRI
criteria proposed by Petersen in 2005 (32) and Jacquier

Newer echocardiographic techniques such as tissue in 2010 (33) are used for LVNC diagnosis. Petersen et
Doppler imaging, strain rate imaging, and speckle al. defined a ratio between non-compacted/compacted
tracking imaging are now available for the diagnosis of layer > 2.3 measured in end-diastole as a cutoff for
LVNC. Global longitudinal strain was found to be lower LVNC. Jacquier et al. calculated the LV trabecular mass
in subjects with LVNC compared with healthy controls in short axis views in end-diastole and concluded that a
even in the presence of normal systolic/diastolic function trabecular mass > 20% was predictive for LVNC.
(29). A recent study also demonstrated that while in

Captur and al. (34) described a recent cardiac MRI

normal individuals and subjects with hypertrophic technique, based on fractal analysis, which does not rely
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on ‘classical’ compacted/non-compacted ratio. A fractal dysfunction or arrhythmias. Patients with normal LV
dimension > 1.3 gave the optimal prediction for LVNC.

size and function will undergo clinical monitoring,

Late gadolinium enhancement (LGE) of trabeculae whereas symptomatic patients with LV dilation and
has also been observed in LVNC. LGE distributions in dysfunction or hypertrophy may be managed according
patients

fulfilling

LVNC

criteria

can

be

very to their clinical needs and corresponding guidelines. In

heterogeneous, which may suggest several distinct later stages, recommendations for treatment follow the
cardiomyopathic processes that are responsible for international guidelines of heart failure management.
LVNC. Small areas of myocardial fibrosis have also Treatment usually requires the combination of betabeen observed in patients with preserved systolic blockers,
function (35).

ACE

inhibitors/ARB,

diuretics,

and

aldosterone antagonists.

Other diagnostic imaging

The main complications related to LVNC are

Computed tomography (CT) is an alternative systemic

thromboembolic

events,

arrhythmias,

method of diagnosing LVNC if the echocardiogram is progressive heart failure, and sudden cardiac death. Oral
non-diagnostic or unavailable (36). Positron emission anticoagulation is a debated issue in the prevention of
tomography (PET), which quantitatively evaluates thromboembolic complications. The question that arises
myocardial blood flow and coronary flow reserve, may is
be

used

to

assess

microcirculatory

whether

anticoagulation

should

be

given

dysfunction independently of arrhythmias or LV dysfunction for

ultimately responsible for the wall motion abnormalities primary prevention of embolic episodes, or only in the
(37).

presence of LV dysfunction, arrhythmias, prior embolic

Differential diagnosis

events, or proven atrial or ventricular thrombi. Left

As there is no diagnostic gold standard, LVNC is ventricular clot and documented atrial fibrillation are
frequently

underdiagnosed

or

misdiagnosed

as clear situations when oral anticoagulation should be

hypertrophic or dilated cardiomyopathy. The differential used. For patients that do not fall into either of these
diagnosis

should

include:

apical

hypertrophic categories, Bennet et al. suggest a risk assessment using

cardiomyopathy, left ventricular hypertrophy, dilated the CHADS2/CHA2DS2-Vasc scores as guidance and a
cardiomyopathy,

arrhythmogenic

left

ventricular discussion with the patient regarding the risks and

dysplasia, myocardial/endocardial fibroelastosis, cardiac benefits of anticoagulation (38).
tumors, left ventricular apical thrombus, normal heart

Sudden

cardiac

death is

another

concerning

with left ventricular prominent trabeculations (less than complication of LVNC. Patients should be periodically
3 trabeculations in echocardiography). Usually, a careful evaluated by Holter ECG for ventricular arrhythmias.
echocardiography study by a trained examiner will The incidence of ventricular arrhythmias rises from 2%
provide the diagnosis. A major challenge is to to 62% in patients with LVNC. Those with sustained
differentiate LVNC with dilated left ventricle from ventricular arrhythmia and those who have experienced
dilated cardiomyopathy.
Management of LVNC

an episode of cardiac arrest require ICD implantation.
Although data regarding anti-arrhythmic therapy are

Currently no specific guidelines exist for the scant, recent research supports the idea of early
treatment of LVNC. Clinical management of LVNC aggressive therapy, including defibrillator and evaluation
depends on the presence or absence of cardiac for cardiac transplant, for patients with bundle brunch
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block, increased left ventricle end-diastolic diameter, or

heterogeneous disorder. Acta Cardiol. 2015; 70(6):

permanent or persistent atrial fibrillation in III-IV

625-31. PMID: 26717209,

NYHA functional class.

DOI: 10.2143/AC.70.6.3120173

Echocardiographic screening is also recommended 2. Towbin JA, Lorts A, Jefferies JL. Left ventricular
for family members, given that the symptoms are

non-compaction cardiomyopathy.

variable and the risks include heart failure and sudden

386(9995):

cardiac death. Genetic testing for LVNC does not change

10.1016/S0140-6736(14)61282-4

813-25.

PMID:

Lancet

2015;

25865865,

DOI:

clinical management of the disease; however, it may be 3. Chin TK, Perloff JK, Williams RG, Jue K,
helpful for confirming diagnosis in family members.

Mohrmann R. Isolated noncompaction of left

Prognosis

ventricular myocardium. A study of eight cases.

LVNC is associated with high morbidity and

Circulation 1990; 82(2): 507–13, PMID: 2372897

mortality rates although prognosis has significantly 4. Arbustini E, Weidemann F, Hall JL. Left ventricular
improved in recent years through earlier diagnosis and

noncompaction: A distinct cardiomyopathy or a trait

use of heart failure medications and device therapy. In

shared by different cardiac diseases? J Am Coll

one Swiss cohort, 35% of patients suffered early death,

Cardiol.2014; 64(17): 1840–50. PMID: 25443708,

53% required hospitalization for congestive heart failure,

DOI: 10.1016/j.jacc.2014.08.030

41% had ventricular tachyarrhythmia, 12% required 5. Weir-McCall JR, Yeap PM, Papagiorcopulo C,
ICDs, and 12% required heart transplantation over 44

Fitzgerald K, Gandy SJ, Lambert M, Belch JJ,

months of follow-up (39). In another recent study,

CavinI, Littleford R, Macfarlane JA, Matthew SZ,

among 45 patients referred to a cardiomyopathy center,

Nicholas RS, Struthers AD, Sullivan F, Waugh SA,

survival free of transplantation was 97% over 4 years of

White

follow-up (40).

noncompaction: Anatomical Phenotype or Distinct

RD,

Houston

JG.

Left

ventricular

Cardiomyopathy? J Am Coll Cardiol. 2016; 68(20):

Conclusions

2157–65. PMID: 27855805,

LVNC is a rare cardiomyopathy associated with

DOI: 10.1016/j.jacc.2016.08.054

significant morbidity and mortality. The diagnosis 6. Elliott P, Andersson B, Arbustini E, Bilinska Z,
remains challenging and a multimodal diagnostic
Cecchi F, Charron P, Dubourg O, Kühl U, Maisch
approach is currently recommended. The classical
B, McKenna WJ, Monserrat L, Pankuweit S,
clinical presentation is the triad of heart failure,

Rapezzi C, Seferovic P, Tavazzi L, Keren A.

arrhythmias, and embolic events. There are no consensus

Classification of the cardiomyopathies: A position

guidelines for the management of these patients.

statement from the european society of cardiology
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